中村 英二郎

Last Update: 2019/06/13 18:00:25

Print

Name(Kanji/Kana/Abecedarium Latinum)
中村 英二郎/ナカムラ エイジロウ/Nakamura, Eijiro
Primary Affiliation(Org1/Job title)
Graduate Schools Medicine/Program-Specific Associate Professor
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
Personal Profile
(Japanese)
(1)新規樹立前立腺癌細胞株を用いた去勢抵抗性前立腺癌に対する治療標的分子の同定 (2)患者由来 iPS 細胞を用いたVHL病疾患モデルの構築 3)研究概要:  これまで自身が診療、及び、Global Clinical Trailに関わってきた各種のGenitourinary Tumorに特徴的な病態(Phenotype)に注目し、分子生物学的手法を用いることにより発癌機構、病期進展の解明を行っています。得られた知見に基づき、本プロジェクトにおいて治療標的分子の同定、新規薬剤の開発を行っています。
(English)
My research focuses on the development of new drugs for Renal Cell Carcinoma (RCC) and Castration-Resistant Prostate Cancer (CRPC). As a medical doctor, I was involved in the treatment of hundreds of patients with both RCC and CRPC. Importantly, I organized several clinical trials for these malignant diseases such as BAY43-9006 (Sorafenib), RP56976(Docetaxel), and ZD4054 as an institutional PI. In these 10 years, I also have been involved in the translational research on those tumors and clarified molecular mechanisms mediating tumorigenesis and disease progression (i.e. Cancer Cell 2002, Cancer Cell 2005, J Clin Oncol. 2007, Cancer Res 2010, Oncogene 2012).My research interests are in the area of Genitourinary tumor.
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
I. Ikeda; T. Mizowaki; Y. Norihisa; K. Takayama; T. Kamba; T. Inoue; E. Nakamura; T. Kamoto; O. Ogawa; M. Hiraoka I. Ikeda; T. Mizowaki; Y. Norihisa; K. Takayama; T. Kamba; T. Inoue; E. Nakamura; T. Kamoto; O. Ogawa; M. Hiraoka I. Ikeda; T. Mizowaki; Y. Norihisa; K. Takayama; T. Kamba; T. Inoue; E. Nakamura; T. Kamoto; O. Ogawa; M. Hiraoka Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: Case series study Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: Case series study Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: Case series study Japanese Journal of Clinical Oncology, 44, 2, 180-185 Japanese Journal of Clinical Oncology, 44, 2, 180-185 Japanese Journal of Clinical Oncology, 44, 2, 180-185 2014 Refereed English Disclose to all
Y. Kajita; T. Kato Jr.; S. Tamaki; M. Furu; R. Takahashi; S. Nagayama; T. Aoyama; H. Nishiyama; E. Nakamura; T. Katagiri; Y. Nakamura; O. Ogawa; J. Toguchida Y. Kajita; T. Kato Jr.; S. Tamaki; M. Furu; R. Takahashi; S. Nagayama; T. Aoyama; H. Nishiyama; E. Nakamura; T. Katagiri; Y. Nakamura; O. Ogawa; J. Toguchida Y. Kajita; T. Kato Jr.; S. Tamaki; M. Furu; R. Takahashi; S. Nagayama; T. Aoyama; H. Nishiyama; E. Nakamura; T. Katagiri; Y. Nakamura; O. Ogawa; J. Toguchida The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1) The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1) The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1) PLoS ONE, 8, 1 PLoS ONE, 8, 1 PLoS ONE, 8, 1 2013 Refereed English Disclose to all
R. Saito; R. Shirakawa; H. Nishiyama; T. Kobayashi; M. Kawato; T. Kanno; K. Nishizawa; Y. Matsui; T. Ohbayashi; M. Horiguchi; T. Nakamura; T. Ikeda; K. Yamane; E. Nakayama; E. Nakamura; Y. Toda; T. Kimura; T. Kita; O. Ogawa; H. Horiuchi R. Saito; R. Shirakawa; H. Nishiyama; T. Kobayashi; M. Kawato; T. Kanno; K. Nishizawa; Y. Matsui; T. Ohbayashi; M. Horiguchi; T. Nakamura; T. Ikeda; K. Yamane; E. Nakayama; E. Nakamura; Y. Toda; T. Kimura; T. Kita; O. Ogawa; H. Horiuchi R. Saito; R. Shirakawa; H. Nishiyama; T. Kobayashi; M. Kawato; T. Kanno; K. Nishizawa; Y. Matsui; T. Ohbayashi; M. Horiguchi; T. Nakamura; T. Ikeda; K. Yamane; E. Nakayama; E. Nakamura; Y. Toda; T. Kimura; T. Kita; O. Ogawa; H. Horiuchi Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer Oncogene, 32, 7, 894-902 Oncogene, 32, 7, 894-902 Oncogene, 32, 7, 894-902 2013 Refereed English Disclose to all
L. Li; C. Shen; E. Nakamura; K. Ando; S. Signoretti; R. Beroukhim; G. Cowley; P. Lizotte; E. Liberzon; S. Bair; D. Root; P. Tamayo; A. Tsherniak; S.-C. Cheng; B. Tabak; A. Jacobsen; A. Hakimi; N. Schultz; G. Ciriello; C. Sander; J. Hsieh; W. Kaelin L. Li; C. Shen; E. Nakamura; K. Ando; S. Signoretti; R. Beroukhim; G. Cowley; P. Lizotte; E. Liberzon; S. Bair; D. Root; P. Tamayo; A. Tsherniak; S.-C. Cheng; B. Tabak; A. Jacobsen; A. Hakimi; N. Schultz; G. Ciriello; C. Sander; J. Hsieh; W. Kaelin L. Li; C. Shen; E. Nakamura; K. Ando; S. Signoretti; R. Beroukhim; G. Cowley; P. Lizotte; E. Liberzon; S. Bair; D. Root; P. Tamayo; A. Tsherniak; S.-C. Cheng; B. Tabak; A. Jacobsen; A. Hakimi; N. Schultz; G. Ciriello; C. Sander; J. Hsieh; W. Kaelin SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer Cancer Cell, 24, 6, 738-750 Cancer Cell, 24, 6, 738-750 Cancer Cell, 24, 6, 738-750 2013 Refereed English Disclose to all
T. Kanno; T. Kamba; T. Yamasaki; N. Shibasaki; R. Saito; N. Terada; Y. Toda; Y. Mikami; T. Inoue; A. Kanematsu; H. Nishiyama; O. Ogawa; E. Nakamura T. Kanno; T. Kamba; T. Yamasaki; N. Shibasaki; R. Saito; N. Terada; Y. Toda; Y. Mikami; T. Inoue; A. Kanematsu; H. Nishiyama; O. Ogawa; E. Nakamura T. Kanno; T. Kamba; T. Yamasaki; N. Shibasaki; R. Saito; N. Terada; Y. Toda; Y. Mikami; T. Inoue; A. Kanematsu; H. Nishiyama; O. Ogawa; E. Nakamura JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma Oncogene, 31, 25, 3098-3110 Oncogene, 31, 25, 3098-3110 Oncogene, 31, 25, 3098-3110 2012 Refereed English Disclose to all
T. Yamasaki; T. Kamba; T. Kanno; T. Inoue; N. Shibasaki; R. Arakaki; T. Yamada; K. Kondo; T. Kamoto; H. Nishiyama; O. Ogawa; E. Nakamura T. Yamasaki; T. Kamba; T. Kanno; T. Inoue; N. Shibasaki; R. Arakaki; T. Yamada; K. Kondo; T. Kamoto; H. Nishiyama; O. Ogawa; E. Nakamura T. Yamasaki; T. Kamba; T. Kanno; T. Inoue; N. Shibasaki; R. Arakaki; T. Yamada; K. Kondo; T. Kamoto; H. Nishiyama; O. Ogawa; E. Nakamura Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy Cancer Science, 103, 11, 2027-2037 Cancer Science, 103, 11, 2027-2037 Cancer Science, 103, 11, 2027-2037 2012 Refereed English Disclose to all
T. Mizuno; M. Fukudo; T. Terada; T. Kamba; E. Nakamura; O. Ogawa; K.-I. Inui; T. Katsura T. Mizuno; M. Fukudo; T. Terada; T. Kamba; E. Nakamura; O. Ogawa; K.-I. Inui; T. Katsura T. Mizuno; M. Fukudo; T. Terada; T. Kamba; E. Nakamura; O. Ogawa; K.-I. Inui; T. Katsura Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics Drug Metabolism and Pharmacokinetics, 27, 6, 631-639 Drug Metabolism and Pharmacokinetics, 27, 6, 631-639 Drug Metabolism and Pharmacokinetics, 27, 6, 631-639 2012 Refereed English Disclose to all
Y. Shimizu; Y. Hamazaki; M. Hattori; K. Doi; N. Terada; T. Kobayashi; Y. Toda; T. Yamasaki; T. Inoue; Y. Kajita; A. Maeno; T. Kamba; Y. Mikami; T. Kamoto; T. Yamada; T. Kanno; K. Yoshikawa; O. Ogawa; N. Minato; E. Nakamura Y. Shimizu; Y. Hamazaki; M. Hattori; K. Doi; N. Terada; T. Kobayashi; Y. Toda; T. Yamasaki; T. Inoue; Y. Kajita; A. Maeno; T. Kamba; Y. Mikami; T. Kamoto; T. Yamada; T. Kanno; K. Yoshikawa; O. Ogawa; N. Minato; E. Nakamura Y. Shimizu; Y. Hamazaki; M. Hattori; K. Doi; N. Terada; T. Kobayashi; Y. Toda; T. Yamasaki; T. Inoue; Y. Kajita; A. Maeno; T. Kamba; Y. Mikami; T. Kamoto; T. Yamada; T. Kanno; K. Yoshikawa; O. Ogawa; N. Minato; E. Nakamura SPA-1 controls the invasion and metastasis of human prostate cancer SPA-1 controls the invasion and metastasis of human prostate cancer SPA-1 controls the invasion and metastasis of human prostate cancer Cancer Science, 102, 4, 828-836 Cancer Science, 102, 4, 828-836 Cancer Science, 102, 4, 828-836 2011/04 Refereed English Disclose to all
M. Sakamoto; T. Mizowaki; M. Mitsumori; K. Takayama; K. Sasai; Y. Norihisa; T. Kamoto; E. Nakamura; O. Ogawa; M. Hiraoka M. Sakamoto; T. Mizowaki; M. Mitsumori; K. Takayama; K. Sasai; Y. Norihisa; T. Kamoto; E. Nakamura; O. Ogawa; M. Hiraoka M. Sakamoto; T. Mizowaki; M. Mitsumori; K. Takayama; K. Sasai; Y. Norihisa; T. Kamoto; E. Nakamura; O. Ogawa; M. Hiraoka Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy in Japanese patients with locally advanced prostate cancer International Journal of Clinical Oncology, 15, 6, 571-577 International Journal of Clinical Oncology, 15, 6, 571-577 International Journal of Clinical Oncology, 15, 6, 571-577 2010/12 Refereed English Disclose to all
N. Terada; Y. Shimizu; T. Yoshida; A. Maeno; T. Kamba; T. Inoue; E. Nakamura; T. Kamoto; O. Ogawa N. Terada; Y. Shimizu; T. Yoshida; A. Maeno; T. Kamba; T. Inoue; E. Nakamura; T. Kamoto; O. Ogawa N. Terada; Y. Shimizu; T. Yoshida; A. Maeno; T. Kamba; T. Inoue; E. Nakamura; T. Kamoto; O. Ogawa Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft Prostate, 70, 3, 252-261 Prostate, 70, 3, 252-261 Prostate, 70, 3, 252-261 2010 Refereed English Disclose to all
N. Terada; Y. Shimizu; T. Kamba; T. Inoue; A. Maeno; T. Kobayashi; E. Nakamura; T. Kamoto; T. Kanaji; T. Maruyama; Y. Mikami; Y. Toda; T. Matsuoka; Y. Okuno; G. Tsujimoto; S. Narumiya; O. Ogawa N. Terada; Y. Shimizu; T. Kamba; T. Inoue; A. Maeno; T. Kobayashi; E. Nakamura; T. Kamoto; T. Kanaji; T. Maruyama; Y. Mikami; Y. Toda; T. Matsuoka; Y. Okuno; G. Tsujimoto; S. Narumiya; O. Ogawa N. Terada; Y. Shimizu; T. Kamba; T. Inoue; A. Maeno; T. Kobayashi; E. Nakamura; T. Kamoto; T. Kanaji; T. Maruyama; Y. Mikami; Y. Toda; T. Matsuoka; Y. Okuno; G. Tsujimoto; S. Narumiya; O. Ogawa Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model Cancer Research, 70, 4, 1606-1615 Cancer Research, 70, 4, 1606-1615 Cancer Research, 70, 4, 1606-1615 2010 Refereed English Disclose to all
T. Kobayashi; T. Inoue; Y. Shimizu; N. Terada; A. Maeno; Y. Kajita; T. Yamasaki; T. Kamba; Y. Toda; Y. Mikami; T. Yamada; T. Kamoto; O. Ogawa; E. Nakamura T. Kobayashi; T. Inoue; Y. Shimizu; N. Terada; A. Maeno; Y. Kajita; T. Yamasaki; T. Kamba; Y. Toda; Y. Mikami; T. Yamada; T. Kamoto; O. Ogawa; E. Nakamura T. Kobayashi; T. Inoue; Y. Shimizu; N. Terada; A. Maeno; Y. Kajita; T. Yamasaki; T. Kamba; Y. Toda; Y. Mikami; T. Yamada; T. Kamoto; O. Ogawa; E. Nakamura Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo Molecular Endocrinology, 24, 4, 722-734 Molecular Endocrinology, 24, 4, 722-734 Molecular Endocrinology, 24, 4, 722-734 2010 Refereed English Disclose to all
T. Kobayashi; Y. Shimizu; N. Terada; T. Yamasaki; E. Nakamura; Y. Toda; H. Nishiyama; T. Kamoto; O. Ogawa; T. Inoue T. Kobayashi; Y. Shimizu; N. Terada; T. Yamasaki; E. Nakamura; Y. Toda; H. Nishiyama; T. Kamoto; O. Ogawa; T. Inoue T. Kobayashi; Y. Shimizu; N. Terada; T. Yamasaki; E. Nakamura; Y. Toda; H. Nishiyama; T. Kamoto; O. Ogawa; T. Inoue Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation Prostate, 70, 8, 866-874 Prostate, 70, 8, 866-874 Prostate, 70, 8, 866-874 2010 Refereed English Disclose to all
T. Mizuno; T. Terada; T. Kamba; M. Fukudo; T. Katsura; E. Nakamura; O. Ogawa; K. Inui T. Mizuno; T. Terada; T. Kamba; M. Fukudo; T. Katsura; E. Nakamura; O. Ogawa; K. Inui T. Mizuno; T. Terada; T. Kamba; M. Fukudo; T. Katsura; E. Nakamura; O. Ogawa; K. Inui ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma Annals of Oncology, 21, 6, 1382-1383 Annals of Oncology, 21, 6, 1382-1383 Annals of Oncology, 21, 6, 1382-1383 2010 Refereed English Disclose to all
K. Shinsako; T. Mizuno; T. Terada; J. Watanabe; T. Kamba; E. Nakamura; O. Ogawa; K.-I. Inui K. Shinsako; T. Mizuno; T. Terada; J. Watanabe; T. Kamba; E. Nakamura; O. Ogawa; K.-I. Inui K. Shinsako; T. Mizuno; T. Terada; J. Watanabe; T. Kamba; E. Nakamura; O. Ogawa; K.-I. Inui Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: A case study Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: A case study Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: A case study International Journal of Clinical Oncology, 15, 5, 512-514 International Journal of Clinical Oncology, 15, 5, 512-514 International Journal of Clinical Oncology, 15, 5, 512-514 2010 Refereed English Disclose to all
T. Inoue; T. Segawa; T. Kamba; K. Yoshimura; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; T. Habuchi; O. Ogawa T. Inoue; T. Segawa; T. Kamba; K. Yoshimura; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; T. Habuchi; O. Ogawa T. Inoue; T. Segawa; T. Kamba; K. Yoshimura; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; T. Habuchi; O. Ogawa Prevalence of Skeletal Complications and Their Impact on Survival of Hormone Refractory Prostate Cancer Patients in Japan Prevalence of Skeletal Complications and Their Impact on Survival of Hormone Refractory Prostate Cancer Patients in Japan Prevalence of Skeletal Complications and Their Impact on Survival of Hormone Refractory Prostate Cancer Patients in Japan Urology, 73, 5, 1104-1109 Urology, 73, 5, 1104-1109 Urology, 73, 5, 1104-1109 2009 Refereed English Disclose to all
T. Kobayashi; E. Nakamura; Y. Shimizu; N. Terada; A. Maeno; G. Kobori; T. Kamba; T. Kamoto; O. Ogawa; T. Inoue T. Kobayashi; E. Nakamura; Y. Shimizu; N. Terada; A. Maeno; G. Kobori; T. Kamba; T. Kamoto; O. Ogawa; T. Inoue T. Kobayashi; E. Nakamura; Y. Shimizu; N. Terada; A. Maeno; G. Kobori; T. Kamba; T. Kamoto; O. Ogawa; T. Inoue Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells Biochemical and Biophysical Research Communications, 387, 1, 196-201 Biochemical and Biophysical Research Communications, 387, 1, 196-201 Biochemical and Biophysical Research Communications, 387, 1, 196-201 2009 Refereed English Disclose to all
M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Annals of Oncology, 21, 1, 189-190 Annals of Oncology, 21, 1, 189-190 Annals of Oncology, 21, 1, 189-190 2009 Refereed English Disclose to all
R. Iguchi; A. Kanematsu; E. Nakamura; T. Shimizu; J. Watanabe; T. Soda; T. Kamba; K. Yoshimura; H. Nishiyama; T. Kamoto; O. Ogawa R. Iguchi; A. Kanematsu; E. Nakamura; T. Shimizu; J. Watanabe; T. Soda; T. Kamba; K. Yoshimura; H. Nishiyama; T. Kamoto; O. Ogawa Two-stage nephron-sparing surgery for bilateral t2 renal cell carcinoma and von hippel-lindau disease: a case report Two-stage nephron-sparing surgery for bilateral t2 renal cell carcinoma and von hippel-lindau disease: a case report Acta Urologica Japonica, 55, 8, 483-485 Acta Urologica Japonica, 55, 8, 483-485 , 55, 8, 483-485 2009 Refereed Japanese Disclose to all
M. Uegaki; T. Kamba; M. Ueda; K. Okasyo; T. Sano; K. Masui; H. Negoro; T. Soda; K. Yoshimura; A. Kanematsu; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa M. Uegaki; T. Kamba; M. Ueda; K. Okasyo; T. Sano; K. Masui; H. Negoro; T. Soda; K. Yoshimura; A. Kanematsu; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa Renal artery pseudoaneurysm following retroperitoneal laparoscopic partial nephrectomy Renal artery pseudoaneurysm following retroperitoneal laparoscopic partial nephrectomy Acta Urologica Japonica, 55, 8, 499-502 Acta Urologica Japonica, 55, 8, 499-502 , 55, 8, 499-502 2009 Refereed Japanese Disclose to all
Y. Shiraishi; K. Yoshimura; T. Inoue; K. Okubo; J. Watanabe; T. Kamba; A. Kanematsu; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa Y. Shiraishi; K. Yoshimura; T. Inoue; K. Okubo; J. Watanabe; T. Kamba; A. Kanematsu; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa One year follow-up results of urinary incontinence and sexual function after holmium laser enucleation of the prostate One year follow-up results of urinary incontinence and sexual function after holmium laser enucleation of the prostate Acta Urologica Japonica, 55, 9, 539-543 Acta Urologica Japonica, 55, 9, 539-543 , 55, 9, 539-543 2009 Refereed Japanese Disclose to all
M. Okamura; T. Kamba; A. Kanematsu; J. Watanabe; T. Shimizu; T. Soda; K. Yoshimura; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa M. Okamura; T. Kamba; A. Kanematsu; J. Watanabe; T. Shimizu; T. Soda; K. Yoshimura; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa M. Okamura; T. Kamba; A. Kanematsu; J. Watanabe; T. Shimizu; T. Soda; K. Yoshimura; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer A case of elderly donor in living kidney transplant after radical radiotherapy for prostate cancer Acta Urologica Japonica, 55, 10, 623-625 Acta Urologica Japonica, 55, 10, 623-625 Acta Urologica Japonica, 55, 10, 623-625 2009 Refereed English Disclose to all
K. Masui; K. Yoshimura; T. Soda; T. Kamba; A. Kanematsu; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa K. Masui; K. Yoshimura; T. Soda; T. Kamba; A. Kanematsu; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa K. Masui; K. Yoshimura; T. Soda; T. Kamba; A. Kanematsu; E. Nakamura; H. Nishiyama; T. Kamoto; O. Ogawa Health-care seeking behavior related to lower urinary tract symptoms: A population-based study in Japan Health-care seeking behavior related to lower urinary tract symptoms: A population-based study in Japan Health-care seeking behavior related to lower urinary tract symptoms: A population-based study in Japan Acta Urologica Japonica, 55, 11, 685-689 Acta Urologica Japonica, 55, 11, 685-689 Acta Urologica Japonica, 55, 11, 685-689 2009 Refereed English Disclose to all
H. Kawanishi; Y. Matsui; M. Ito; J. Watanabe; T. Takahashi; K. Nishizawa; H. Nishiyama; T. Kamoto; Y. Mikami; Y. Tanaka; G. Jung; H. Akiyama; H. Nobumasa; P. Guilford; A. Reeve; Y. Okuno; G. Tsujimoto; E. Nakamura; O. Ogawa H. Kawanishi; Y. Matsui; M. Ito; J. Watanabe; T. Takahashi; K. Nishizawa; H. Nishiyama; T. Kamoto; Y. Mikami; Y. Tanaka; G. Jung; H. Akiyama; H. Nobumasa; P. Guilford; A. Reeve; Y. Okuno; G. Tsujimoto; E. Nakamura; O. Ogawa H. Kawanishi; Y. Matsui; M. Ito; J. Watanabe; T. Takahashi; K. Nishizawa; H. Nishiyama; T. Kamoto; Y. Mikami; Y. Tanaka; G. Jung; H. Akiyama; H. Nobumasa; P. Guilford; A. Reeve; Y. Okuno; G. Tsujimoto; E. Nakamura; O. Ogawa Secreted CXCL1 Is a potential mediator and marker of the tumor invasion of bladder cancer Secreted CXCL1 Is a potential mediator and marker of the tumor invasion of bladder cancer Secreted CXCL1 Is a potential mediator and marker of the tumor invasion of bladder cancer Clinical Cancer Research, 14, 9, 2579-2587 Clinical Cancer Research, 14, 9, 2579-2587 Clinical Cancer Research, 14, 9, 2579-2587 2008 Refereed English Disclose to all
Y. Awakura; E. Nakamura; N. Ito; T. Kamoto; O. Ogawa Y. Awakura; E. Nakamura; N. Ito; T. Kamoto; O. Ogawa Y. Awakura; E. Nakamura; N. Ito; T. Kamoto; O. Ogawa Methylation-associated silencing of TU3A in human cancers Methylation-associated silencing of TU3A in human cancers Methylation-associated silencing of TU3A in human cancers International Journal of Oncology, 33, 4, 893-899 International Journal of Oncology, 33, 4, 893-899 International Journal of Oncology, 33, 4, 893-899 2008 Refereed English Disclose to all
Y. Awakura; E. Nakamura; T. Takahashi; H. Kotani; Y. Mikami; T. Kadowaki; A. Myoumoto; H. Akiyama; N. Ito; T. Kamoto; T. Manabe; H. Nobumasa; G. Tsujimoto; O. Ogawa Y. Awakura; E. Nakamura; T. Takahashi; H. Kotani; Y. Mikami; T. Kadowaki; A. Myoumoto; H. Akiyama; N. Ito; T. Kamoto; T. Manabe; H. Nobumasa; G. Tsujimoto; O. Ogawa Y. Awakura; E. Nakamura; T. Takahashi; H. Kotani; Y. Mikami; T. Kadowaki; A. Myoumoto; H. Akiyama; N. Ito; T. Kamoto; T. Manabe; H. Nobumasa; G. Tsujimoto; O. Ogawa Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma Journal of Cancer Research and Clinical Oncology, 134, 12, 1363-1369 Journal of Cancer Research and Clinical Oncology, 134, 12, 1363-1369 Journal of Cancer Research and Clinical Oncology, 134, 12, 1363-1369 2008 Refereed English Disclose to all
N. Terada; N. Tsuchiya; Z. Ma; Y. Shimizu; T. Kobayashi; E. Nakamura; T. Kamoto; T. Habuchi; O. Ogawa N. Terada; N. Tsuchiya; Z. Ma; Y. Shimizu; T. Kobayashi; E. Nakamura; T. Kamoto; T. Habuchi; O. Ogawa N. Terada; N. Tsuchiya; Z. Ma; Y. Shimizu; T. Kobayashi; E. Nakamura; T. Kamoto; T. Habuchi; O. Ogawa Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population Prostate, 68, 15, 1689-1695 Prostate, 68, 15, 1689-1695 Prostate, 68, 15, 1689-1695 2008 Refereed English Disclose to all
Y. Awakura; E. Nakamura; N. Ito; T. Kamoto; O. Ogawa Y. Awakura; E. Nakamura; N. Ito; T. Kamoto; O. Ogawa Y. Awakura; E. Nakamura; N. Ito; T. Kamoto; O. Ogawa Methylation-associated silencing of SFRP1 in renal cell carcinoma Methylation-associated silencing of SFRP1 in renal cell carcinoma Methylation-associated silencing of SFRP1 in renal cell carcinoma Oncology Reports, 20, 5, 1257-1263 Oncology Reports, 20, 5, 1257-1263 Oncology Reports, 20, 5, 1257-1263 2008 Refereed English Disclose to all
K. Masui; T. Kamba; J. Watanabe; T. Soda; K. Yoshimura; A. Kanematsu; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa K. Masui; T. Kamba; J. Watanabe; T. Soda; K. Yoshimura; A. Kanematsu; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa K. Masui; T. Kamba; J. Watanabe; T. Soda; K. Yoshimura; A. Kanematsu; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa A case of small cell carcinoma of the ureter A case of small cell carcinoma of the ureter A case of small cell carcinoma of the ureter Acta Urologica Japonica, 54, 6, 411-413 Acta Urologica Japonica, 54, 6, 411-413 Acta Urologica Japonica, 54, 6, 411-413 2008 Refereed English Disclose to all
A. Sengiku; H. Nishiyama; T. Shimizu; J. Watabe; T. Soda; T. Kamba; K. Yoshimura; A. Kanematsu; E. Nakamura; T. Kamoto; O. Ogawa A. Sengiku; H. Nishiyama; T. Shimizu; J. Watabe; T. Soda; T. Kamba; K. Yoshimura; A. Kanematsu; E. Nakamura; T. Kamoto; O. Ogawa Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: Comparison between renal pelvic and ureteral tumors Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: Comparison between renal pelvic and ureteral tumors Acta Urologica Japonica, 54, 11, 703-709 Acta Urologica Japonica, 54, 11, 703-709 , 54, 11, 703-709 2008 Refereed Japanese Disclose to all
Y. Shimizu; T. Segawa; T. Inoue; T. Shiraishi; T. Yoshida; Y. Toda; T. Yamada; N. Kinukawa; N. Terada; T. Kobayashi; H. Kinoshita; T. Kamoto; E. Nakamura; O. Ogawa Y. Shimizu; T. Segawa; T. Inoue; T. Shiraishi; T. Yoshida; Y. Toda; T. Yamada; N. Kinukawa; N. Terada; T. Kobayashi; H. Kinoshita; T. Kamoto; E. Nakamura; O. Ogawa Y. Shimizu; T. Segawa; T. Inoue; T. Shiraishi; T. Yoshida; Y. Toda; T. Yamada; N. Kinukawa; N. Terada; T. Kobayashi; H. Kinoshita; T. Kamoto; E. Nakamura; O. Ogawa Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men BJU International, 100, 3, 685-690 BJU International, 100, 3, 685-690 BJU International, 100, 3, 685-690 2007/09 Refereed English Disclose to all
Y. Awakura; E. Nakamura; N. Ito; T. Yamasaki; T. Kamba; T. Kamoto; O. Ogawa Y. Awakura; E. Nakamura; N. Ito; T. Yamasaki; T. Kamba; T. Kamoto; O. Ogawa Y. Awakura; E. Nakamura; N. Ito; T. Yamasaki; T. Kamba; T. Kamoto; O. Ogawa Influence of Body Mass Index on Prognosis of Japanese Patients with Renal Cell Carcinoma Influence of Body Mass Index on Prognosis of Japanese Patients with Renal Cell Carcinoma Influence of Body Mass Index on Prognosis of Japanese Patients with Renal Cell Carcinoma Urology, 70, 1, 50-54 Urology, 70, 1, 50-54 Urology, 70, 1, 50-54 2007 Refereed English Disclose to all
N. Ito; M. Eto; E. Nakamura; A. Takahashi; T. Tsukamoto; H. Toma; H. Nakazawa; Y. Hirao; H. Uemura; S. Kagawa; H. Kanayama; Y. Nose; N. Kinukawa; T. Nakamura; N. Jinnai; T. Seki; M. Takamatsu; Y. Masui; S. Naito; O. Ogawa N. Ito; M. Eto; E. Nakamura; A. Takahashi; T. Tsukamoto; H. Toma; H. Nakazawa; Y. Hirao; H. Uemura; S. Kagawa; H. Kanayama; Y. Nose; N. Kinukawa; T. Nakamura; N. Jinnai; T. Seki; M. Takamatsu; Y. Masui; S. Naito; O. Ogawa N. Ito; M. Eto; E. Nakamura; A. Takahashi; T. Tsukamoto; H. Toma; H. Nakazawa; Y. Hirao; H. Uemura; S. Kagawa; H. Kanayama; Y. Nose; N. Kinukawa; T. Nakamura; N. Jinnai; T. Seki; M. Takamatsu; Y. Masui; S. Naito; O. Ogawa STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma Journal of Clinical Oncology, 25, 19, 2785-2791 Journal of Clinical Oncology, 25, 19, 2785-2791 Journal of Clinical Oncology, 25, 19, 2785-2791 2007 Refereed English Disclose to all
M. Jiko; I. Yano; E. Sato; K. Takahashi; H. Motohashi; S. Masuda; M. Okuda; N. Ito; E. Nakamura; T. Segawa; T. Kamoto; O. Ogawa; K.-I. Inui M. Jiko; I. Yano; E. Sato; K. Takahashi; H. Motohashi; S. Masuda; M. Okuda; N. Ito; E. Nakamura; T. Segawa; T. Kamoto; O. Ogawa; K.-I. Inui M. Jiko; I. Yano; E. Sato; K. Takahashi; H. Motohashi; S. Masuda; M. Okuda; N. Ito; E. Nakamura; T. Segawa; T. Kamoto; O. Ogawa; K.-I. Inui Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers International Journal of Clinical Oncology, 12, 4, 284-290 International Journal of Clinical Oncology, 12, 4, 284-290 International Journal of Clinical Oncology, 12, 4, 284-290 2007 Refereed English Disclose to all
K. Yoshimura; T. Kamoto; E. Nakamura; T. Segawa; T. Kamba; T. Takahashi; H. Nishiyama; N. Ito; K. Takayama; T. Mizowaki; M. Mitsumori; M. Hiraoka; O. Ogawa K. Yoshimura; T. Kamoto; E. Nakamura; T. Segawa; T. Kamba; T. Takahashi; H. Nishiyama; N. Ito; K. Takayama; T. Mizowaki; M. Mitsumori; M. Hiraoka; O. Ogawa K. Yoshimura; T. Kamoto; E. Nakamura; T. Segawa; T. Kamba; T. Takahashi; H. Nishiyama; N. Ito; K. Takayama; T. Mizowaki; M. Mitsumori; M. Hiraoka; O. Ogawa Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: Intensity-modulated radiation therapy versus conformal radiation therapy Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: Intensity-modulated radiation therapy versus conformal radiation therapy Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: Intensity-modulated radiation therapy versus conformal radiation therapy Prostate Cancer and Prostatic Diseases, 10, 3, 288-292 Prostate Cancer and Prostatic Diseases, 10, 3, 288-292 Prostate Cancer and Prostatic Diseases, 10, 3, 288-292 2007 Refereed English Disclose to all
H. Kinoshita; T. Kamoto; H. Nishiyama; E. Nakamura; T. Matsuda; O. Ogawa H. Kinoshita; T. Kamoto; H. Nishiyama; E. Nakamura; T. Matsuda; O. Ogawa H. Kinoshita; T. Kamoto; H. Nishiyama; E. Nakamura; T. Matsuda; O. Ogawa Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males International Journal of Urology, 14, 10, 930-934 International Journal of Urology, 14, 10, 930-934 International Journal of Urology, 14, 10, 930-934 2007 Refereed English Disclose to all
T. Inoue; T. Kobayashi; N. Terada; Y. Shimizu; T. Kamoto; O. Ogawa; E. Nakamura T. Inoue; T. Kobayashi; N. Terada; Y. Shimizu; T. Kamoto; O. Ogawa; E. Nakamura T. Inoue; T. Kobayashi; N. Terada; Y. Shimizu; T. Kamoto; O. Ogawa; E. Nakamura Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells Expert Review of Endocrinology and Metabolism, 2, 5, 689-704 Expert Review of Endocrinology and Metabolism, 2, 5, 689-704 Expert Review of Endocrinology and Metabolism, 2, 5, 689-704 2007 Refereed English Disclose to all
T. Mizowaki; K. Takayama; Y. Norihisa; M. Mitsumori; M. Hiraoka; T. Kamoto; E. Nakamura; T. Kanba; O. Ogawa T. Mizowaki; K. Takayama; Y. Norihisa; M. Mitsumori; M. Hiraoka; T. Kamoto; E. Nakamura; T. Kanba; O. Ogawa T. Mizowaki; K. Takayama; Y. Norihisa; M. Mitsumori; M. Hiraoka; T. Kamoto; E. Nakamura; T. Kanba; O. Ogawa External-beam radiotherapy combined with neoadjuvant hormonal therapy External-beam radiotherapy combined with neoadjuvant hormonal therapy External-beam radiotherapy combined with neoadjuvant hormonal therapy Japanese Journal of Clinical Radiology, 52, 5, 635-640 Japanese Journal of Clinical Radiology, 52, 5, 635-640 Japanese Journal of Clinical Radiology, 52, 5, 635-640 2007 Refereed English Disclose to all
T. Sano; H. Nishiyama; A. Kanematsu; T. Takahashi; E. Nakamura; T. Kamoto; Y. Mikami; T. Koyama; O. Ogawa T. Sano; H. Nishiyama; A. Kanematsu; T. Takahashi; E. Nakamura; T. Kamoto; Y. Mikami; T. Koyama; O. Ogawa T. Sano; H. Nishiyama; A. Kanematsu; T. Takahashi; E. Nakamura; T. Kamoto; Y. Mikami; T. Koyama; O. Ogawa Solitary fibrous tumor in the pelvic space: A case report Solitary fibrous tumor in the pelvic space: A case report Solitary fibrous tumor in the pelvic space: A case report Acta Urologica Japonica, 53, 12, 897-901 Acta Urologica Japonica, 53, 12, 897-901 Acta Urologica Japonica, 53, 12, 897-901 2007 Refereed English Disclose to all
E. Nakamura; P. Abreu-E-Lima; Y. Awakura; T. Inoue; T. Kamoto; O. Ogawa; H. Kotani; T. Manabe; G.-J. Zhang; K. Kondo; V. Nosé; W.G. Kaelin Jr. E. Nakamura; P. Abreu-E-Lima; Y. Awakura; T. Inoue; T. Kamoto; O. Ogawa; H. Kotani; T. Manabe; G.-J. Zhang; K. Kondo; V. Nosé; W.G. Kaelin Jr. E. Nakamura; P. Abreu-E-Lima; Y. Awakura; T. Inoue; T. Kamoto; O. Ogawa; H. Kotani; T. Manabe; G.-J. Zhang; K. Kondo; V. Nosé; W.G. Kaelin Jr. Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein American Journal of Pathology, 168, 2, 574-584 American Journal of Pathology, 168, 2, 574-584 American Journal of Pathology, 168, 2, 574-584 2006 Refereed English Disclose to all
T. Takahashi; S. Higashi; H. Nishiyama; T. Segawa; E. Nakamura; H. Kinoshita; N. Itoh; S. Yamamoto; T. Kamoto; T. Habuchi; O. Ogawa T. Takahashi; S. Higashi; H. Nishiyama; T. Segawa; E. Nakamura; H. Kinoshita; N. Itoh; S. Yamamoto; T. Kamoto; T. Habuchi; O. Ogawa T. Takahashi; S. Higashi; H. Nishiyama; T. Segawa; E. Nakamura; H. Kinoshita; N. Itoh; S. Yamamoto; T. Kamoto; T. Habuchi; O. Ogawa Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen Japanese Journal of Clinical Oncology, 36, 2, 104-108 Japanese Journal of Clinical Oncology, 36, 2, 104-108 Japanese Journal of Clinical Oncology, 36, 2, 104-108 2006 Refereed English Disclose to all
A. Hoshi; E. Nakamura; S. Higashi; T. Segawa; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa A. Hoshi; E. Nakamura; S. Higashi; T. Segawa; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa A. Hoshi; E. Nakamura; S. Higashi; T. Segawa; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa Epithelial stromal tumor of the seminal vesicle Epithelial stromal tumor of the seminal vesicle Epithelial stromal tumor of the seminal vesicle International Journal of Urology, 13, 5, 640-642 International Journal of Urology, 13, 5, 640-642 International Journal of Urology, 13, 5, 640-642 2006 Refereed English Disclose to all
T. Inoue; T. Segawa; T. Shiraishi; T. Yamada; N. Kinukawa; T. Yoshida; Y. Toda; Y. Shimizu; E. Nakamura; H. Kinoshita; T. Kamoto; O. Ogawa T. Inoue; T. Segawa; T. Shiraishi; T. Yamada; N. Kinukawa; T. Yoshida; Y. Toda; Y. Shimizu; E. Nakamura; H. Kinoshita; T. Kamoto; O. Ogawa T. Inoue; T. Segawa; T. Shiraishi; T. Yamada; N. Kinukawa; T. Yoshida; Y. Toda; Y. Shimizu; E. Nakamura; H. Kinoshita; T. Kamoto; O. Ogawa High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase BJU International, 98, 1, 197-200 BJU International, 98, 1, 197-200 BJU International, 98, 1, 197-200 2006 Refereed English Disclose to all
T. Inoue; T. Ito; S. Narita; Y. Horikawa; N. Tsuchiya; H. Kakinuma; M. Mishina; E. Nakamura; T. Kato; O. Ogawa; T. Habuchi T. Inoue; T. Ito; S. Narita; Y. Horikawa; N. Tsuchiya; H. Kakinuma; M. Mishina; E. Nakamura; T. Kato; O. Ogawa; T. Habuchi T. Inoue; T. Ito; S. Narita; Y. Horikawa; N. Tsuchiya; H. Kakinuma; M. Mishina; E. Nakamura; T. Kato; O. Ogawa; T. Habuchi Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients Cancer Letters, 240, 1, 41-47 Cancer Letters, 240, 1, 41-47 Cancer Letters, 240, 1, 41-47 2006 Refereed English Disclose to all
T. Inoue; T. Yoshida; Y. Shimizu; T. Kobayashi; T. Yamasaki; Y. Toda; T. Segawa; T. Kamoto; E. Nakamura; O. Ogawa T. Inoue; T. Yoshida; Y. Shimizu; T. Kobayashi; T. Yamasaki; Y. Toda; T. Segawa; T. Kamoto; E. Nakamura; O. Ogawa T. Inoue; T. Yoshida; Y. Shimizu; T. Kobayashi; T. Yamasaki; Y. Toda; T. Segawa; T. Kamoto; E. Nakamura; O. Ogawa Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells Molecular Endocrinology, 20, 12, 3053-3069 Molecular Endocrinology, 20, 12, 3053-3069 Molecular Endocrinology, 20, 12, 3053-3069 2006 Refereed English Disclose to all
E. Nakamura; W.G. Kaelin Jr. E. Nakamura; W.G. Kaelin Jr. E. Nakamura; W.G. Kaelin Jr. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma Endocrine Pathology, 17, 2, 97-106 Endocrine Pathology, 17, 2, 97-106 Endocrine Pathology, 17, 2, 97-106 2006 Refereed English Disclose to all
Y. Awakura; N. Ito; E. Nakamura; T. Takahashi; H. Kotani; Y. Mikami; T. Manabe; T. Kamoto; T. Habuchi; O. Ogawa Y. Awakura; N. Ito; E. Nakamura; T. Takahashi; H. Kotani; Y. Mikami; T. Manabe; T. Kamoto; T. Habuchi; O. Ogawa Y. Awakura; N. Ito; E. Nakamura; T. Takahashi; H. Kotani; Y. Mikami; T. Manabe; T. Kamoto; T. Habuchi; O. Ogawa Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population Cancer Letters, 241, 1, 59-63 Cancer Letters, 241, 1, 59-63 Cancer Letters, 241, 1, 59-63 2006 Refereed English Disclose to all
A. Hoshi; T. Segawa; T. Takahashi; E. Nakamura; S. Higashi; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa A. Hoshi; T. Segawa; T. Takahashi; E. Nakamura; S. Higashi; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa BK virus nephropathy in a kidney transplant recipient: A case report and literature review BK virus nephropathy in a kidney transplant recipient: A case report and literature review Acta Urologica Japonica, 52, 2, 119-123 Acta Urologica Japonica, 52, 2, 119-123 , 52, 2, 119-123 2006 Refereed Japanese Disclose to all
K. Yoshida; E. Nakamura; T. Kawahara; T. Inoue; H. Sawazaki; T. Kamba; K. Yoshimura; T. Takahashi; H. Nishiyama; T. Segawa; N. Ito; T. Kamoto; O. Ogawa; H. Fujii; T. Shiomi; Y. Kotani; Y. Mikami; T. Manabe K. Yoshida; E. Nakamura; T. Kawahara; T. Inoue; H. Sawazaki; T. Kamba; K. Yoshimura; T. Takahashi; H. Nishiyama; T. Segawa; N. Ito; T. Kamoto; O. Ogawa; H. Fujii; T. Shiomi; Y. Kotani; Y. Mikami; T. Manabe K. Yoshida; E. Nakamura; T. Kawahara; T. Inoue; H. Sawazaki; T. Kamba; K. Yoshimura; T. Takahashi; H. Nishiyama; T. Segawa; N. Ito; T. Kamoto; O. Ogawa; H. Fujii; T. Shiomi; Y. Kotani; Y. Mikami; T. Manabe A case of myxoid liposarcoma in the right inguinal region: A case report A case of myxoid liposarcoma in the right inguinal region: A case report A case of myxoid liposarcoma in the right inguinal region: A case report Acta Urologica Japonica, 52, 9, 727-731 Acta Urologica Japonica, 52, 9, 727-731 Acta Urologica Japonica, 52, 9, 727-731 2006 Refereed English Disclose to all
H. Sawazaki; T. Segawa; K. Yoshida; T. Kawahara; T. Inoue; T. Soda; T. Kanba; K. Yoshimura; T. Takahashi; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa H. Sawazaki; T. Segawa; K. Yoshida; T. Kawahara; T. Inoue; T. Soda; T. Kanba; K. Yoshimura; T. Takahashi; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa H. Sawazaki; T. Segawa; K. Yoshida; T. Kawahara; T. Inoue; T. Soda; T. Kanba; K. Yoshimura; T. Takahashi; E. Nakamura; H. Nishiyama; N. Ito; T. Kamoto; O. Ogawa Xanthogranulomatous pyelonephritis presenting a subcutaneous mass in the lower abdomen: A case report Xanthogranulomatous pyelonephritis presenting a subcutaneous mass in the lower abdomen: A case report Xanthogranulomatous pyelonephritis presenting a subcutaneous mass in the lower abdomen: A case report Acta Urologica Japonica, 52, 11, 875-878 Acta Urologica Japonica, 52, 11, 875-878 Acta Urologica Japonica, 52, 11, 875-878 2006 Refereed English Disclose to all
H. Sawazaki; E. Nakamura; A. Hoshi; K. Nishizawa; K. Yoshimura; T. Takahashi; T. Segawa; H. Nishiyama; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa; A. Yoshizawa; H. Kotani; T. Manabe H. Sawazaki; E. Nakamura; A. Hoshi; K. Nishizawa; K. Yoshimura; T. Takahashi; T. Segawa; H. Nishiyama; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa; A. Yoshizawa; H. Kotani; T. Manabe H. Sawazaki; E. Nakamura; A. Hoshi; K. Nishizawa; K. Yoshimura; T. Takahashi; T. Segawa; H. Nishiyama; N. Ito; S. Yamamoto; T. Kamoto; O. Ogawa; A. Yoshizawa; H. Kotani; T. Manabe Well-differentiated inflammatory liposarcoma occurring in the scrotum: A case report Well-differentiated inflammatory liposarcoma occurring in the scrotum: A case report Well-differentiated inflammatory liposarcoma occurring in the scrotum: A case report Acta Urologica Japonica, 52, 12, 961-963 Acta Urologica Japonica, 52, 12, 961-963 Acta Urologica Japonica, 52, 12, 961-963 2006 Refereed English Disclose to all
Y. Megumi; Y. Miyauchi; H. Sakurai; H. Nobeyama; K. Lorick; E. Nakamura; T. Chiba; K. Tanaka; A.M. Weissman; T. Kirisako; O. Ogawa; K. Iwai Y. Megumi; Y. Miyauchi; H. Sakurai; H. Nobeyama; K. Lorick; E. Nakamura; T. Chiba; K. Tanaka; A.M. Weissman; T. Kirisako; O. Ogawa; K. Iwai Y. Megumi; Y. Miyauchi; H. Sakurai; H. Nobeyama; K. Lorick; E. Nakamura; T. Chiba; K. Tanaka; A.M. Weissman; T. Kirisako; O. Ogawa; K. Iwai Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex Genes to Cells, 10, 7, 679-691 Genes to Cells, 10, 7, 679-691 Genes to Cells, 10, 7, 679-691 2005 Refereed English Disclose to all
S. Lee; E. Nakamura; H. Yang; W. Wei; M.S. Linggi; M.P. Sajan; R.V. Farese; R.S. Freeman; B.D. Carter; W.G. Kaelin Jr.; S. Schlisio S. Lee; E. Nakamura; H. Yang; W. Wei; M.S. Linggi; M.P. Sajan; R.V. Farese; R.S. Freeman; B.D. Carter; W.G. Kaelin Jr.; S. Schlisio S. Lee; E. Nakamura; H. Yang; W. Wei; M.S. Linggi; M.P. Sajan; R.V. Farese; R.S. Freeman; B.D. Carter; W.G. Kaelin Jr.; S. Schlisio Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer Cancer Cell, 8, 2, 155-167 Cancer Cell, 8, 2, 155-167 Cancer Cell, 8, 2, 155-167 2005 Refereed English Disclose to all
Z. Niu; M. Ito; Y. Awakura; T. Takahashi; E. Nakamura; N. Ito; O. Ogawa Z. Niu; M. Ito; Y. Awakura; T. Takahashi; E. Nakamura; N. Ito; O. Ogawa Z. Niu; M. Ito; Y. Awakura; T. Takahashi; E. Nakamura; N. Ito; O. Ogawa The expression of NOV and WT1 in renal cell carcinoma: A quantitative reverse transcriptase-polymerase chain reaction analysis The expression of NOV and WT1 in renal cell carcinoma: A quantitative reverse transcriptase-polymerase chain reaction analysis The expression of NOV and WT1 in renal cell carcinoma: A quantitative reverse transcriptase-polymerase chain reaction analysis Journal of Urology, 174, 4 I, 1460-1462 Journal of Urology, 174, 4 I, 1460-1462 Journal of Urology, 174, 4 I, 1460-1462 2005 Refereed English Disclose to all
T. Segawa; T. Kamoto; H. Kinoshita; Y. Kunishima; K. Yoshimura; A. Ito; T. Takahashi; S. Higashi; E. Nakamura; H. Nishiyama; N. Ito; S. Yamamoto; T. Habuchi; O. Ogawa T. Segawa; T. Kamoto; H. Kinoshita; Y. Kunishima; K. Yoshimura; A. Ito; T. Takahashi; S. Higashi; E. Nakamura; H. Nishiyama; N. Ito; S. Yamamoto; T. Habuchi; O. Ogawa T. Segawa; T. Kamoto; H. Kinoshita; Y. Kunishima; K. Yoshimura; A. Ito; T. Takahashi; S. Higashi; E. Nakamura; H. Nishiyama; N. Ito; S. Yamamoto; T. Habuchi; O. Ogawa Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer International Journal of Clinical Oncology, 10, 5, 333-337 International Journal of Clinical Oncology, 10, 5, 333-337 International Journal of Clinical Oncology, 10, 5, 333-337 2005 Refereed English Disclose to all
T. Yoshida; H. Kinoshita; T. Segawa; E. Nakamura; T. Inoue; Y. Shimizu; T. Kamoto; O. Ogawa T. Yoshida; H. Kinoshita; T. Segawa; E. Nakamura; T. Inoue; Y. Shimizu; T. Kamoto; O. Ogawa T. Yoshida; H. Kinoshita; T. Segawa; E. Nakamura; T. Inoue; Y. Shimizu; T. Kamoto; O. Ogawa Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient Cancer Research, 65, 21, 9611-9616 Cancer Research, 65, 21, 9611-9616 Cancer Research, 65, 21, 9611-9616 2005 Refereed English Disclose to all
T. Mizowaki; M. Mitsumori; K. Takayama; Y. Norihisa; M. Sakamoto; M. Hiraoka; K. Sasai; Y. Negoro; T. Kamoto; E. Nakamura; O. Ogawa T. Mizowaki; M. Mitsumori; K. Takayama; Y. Norihisa; M. Sakamoto; M. Hiraoka; K. Sasai; Y. Negoro; T. Kamoto; E. Nakamura; O. Ogawa 3D-CRT and IMRT for prostate cancer 3D-CRT and IMRT for prostate cancer Japanese Journal of Clinical Radiology, 50, 5, 611-618 Japanese Journal of Clinical Radiology, 50, 5, 611-618 , 50, 5, 611-618 2005 Refereed Japanese Disclose to all
T. Kobayashi; E. Nakamura; K. Ogura; O. Ogawa T. Kobayashi; E. Nakamura; K. Ogura; O. Ogawa T. Kobayashi; E. Nakamura; K. Ogura; O. Ogawa Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: Is ipsilateral adrenalectomy indispensable during radical nephrectomy? [2] Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: Is ipsilateral adrenalectomy indispensable during radical nephrectomy? [2] Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: Is ipsilateral adrenalectomy indispensable during radical nephrectomy? [2] BJU International, 96, 6, 916- BJU International, 96, 6, 916- BJU International, 96, 6, 916- 2005 Refereed English Disclose to all
Y. Uwai; S. Masuda; M. Goto; H. Motohashi; H. Saito; M. Okuda; E. Nakamura; N. Ito; O. Ogawa; K.-I. Inui Y. Uwai; S. Masuda; M. Goto; H. Motohashi; H. Saito; M. Okuda; E. Nakamura; N. Ito; O. Ogawa; K.-I. Inui Y. Uwai; S. Masuda; M. Goto; H. Motohashi; H. Saito; M. Okuda; E. Nakamura; N. Ito; O. Ogawa; K.-I. Inui Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients Journal of Human Genetics, 49, 1, 40-45 Journal of Human Genetics, 49, 1, 40-45 Journal of Human Genetics, 49, 1, 40-45 2004/01 Refereed English Disclose to all
S. Ishitoya; H. Kurazono; H. Nishiyama; E. Nakamura; T. Kamoto; T. Habuchi; A. Terai; O. Ogawa; S. Yamamoto S. Ishitoya; H. Kurazono; H. Nishiyama; E. Nakamura; T. Kamoto; T. Habuchi; A. Terai; O. Ogawa; S. Yamamoto S. Ishitoya; H. Kurazono; H. Nishiyama; E. Nakamura; T. Kamoto; T. Habuchi; A. Terai; O. Ogawa; S. Yamamoto Verotoxin induces rapid elimination of human renal tumor xenografts in scid mice Verotoxin induces rapid elimination of human renal tumor xenografts in scid mice Verotoxin induces rapid elimination of human renal tumor xenografts in scid mice Journal of Urology, 171, 3, 1309-1313 Journal of Urology, 171, 3, 1309-1313 Journal of Urology, 171, 3, 1309-1313 2004 Refereed English Disclose to all
S. Kanamaru; A. Terai; S. Ishitoya; Y. Kunishima; H. Nishiyama; T. Segawa; E. Nakamura; H. Kinoshita; S. Moroi; N. Ito; T. Kamoto; H. Okuno; T. Habuchi; K. Senda; S. Ichiyama; O. Ogawa; S. Yamamoto S. Kanamaru; A. Terai; S. Ishitoya; Y. Kunishima; H. Nishiyama; T. Segawa; E. Nakamura; H. Kinoshita; S. Moroi; N. Ito; T. Kamoto; H. Okuno; T. Habuchi; K. Senda; S. Ichiyama; O. Ogawa; S. Yamamoto S. Kanamaru; A. Terai; S. Ishitoya; Y. Kunishima; H. Nishiyama; T. Segawa; E. Nakamura; H. Kinoshita; S. Moroi; N. Ito; T. Kamoto; H. Okuno; T. Habuchi; K. Senda; S. Ichiyama; O. Ogawa; S. Yamamoto Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: A preliminary study Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: A preliminary study Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: A preliminary study International Journal of Urology, 11, 6, 355-363 International Journal of Urology, 11, 6, 355-363 International Journal of Urology, 11, 6, 355-363 2004 Refereed English Disclose to all
J. Yu; T. Habuchi; N. Tsuchiya; E. Nakamura; H. Kakinuma; Y. Horikawa; T. Inoue; O. Ogawa; T. Kato J. Yu; T. Habuchi; N. Tsuchiya; E. Nakamura; H. Kakinuma; Y. Horikawa; T. Inoue; O. Ogawa; T. Kato J. Yu; T. Habuchi; N. Tsuchiya; E. Nakamura; H. Kakinuma; Y. Horikawa; T. Inoue; O. Ogawa; T. Kato Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma Journal of Urology, 172, 6 I, 2410-2413 Journal of Urology, 172, 6 I, 2410-2413 Journal of Urology, 172, 6 I, 2410-2413 2004 Refereed English Disclose to all
K. Nagahama; S. Yamamoto; H. Yoshida; E. Nakamura; N. Ito; H. Kinoshita; T. Kamoto; H. Okuno; O. Ogawa K. Nagahama; S. Yamamoto; H. Yoshida; E. Nakamura; N. Ito; H. Kinoshita; T. Kamoto; H. Okuno; O. Ogawa K. Nagahama; S. Yamamoto; H. Yoshida; E. Nakamura; N. Ito; H. Kinoshita; T. Kamoto; H. Okuno; O. Ogawa Clinical results of immunosuppressive triple therapies in living-related renal transplantation - A single center experience Clinical results of immunosuppressive triple therapies in living-related renal transplantation - A single center experience Clinical results of immunosuppressive triple therapies in living-related renal transplantation - A single center experience Acta Urologica Japonica, 50, 9, 605-610 Acta Urologica Japonica, 50, 9, 605-610 Acta Urologica Japonica, 50, 9, 605-610 2004 Refereed English Disclose to all
K. Nishizawa; E. Nakamura; T. Kobayashi; T. Kamoto; A. Terai; T. Terachi; O. Ogawa; H. Itoh; K. Nakao K. Nishizawa; E. Nakamura; T. Kobayashi; T. Kamoto; A. Terai; T. Terachi; O. Ogawa; H. Itoh; K. Nakao K. Nishizawa; E. Nakamura; T. Kobayashi; T. Kamoto; A. Terai; T. Terachi; O. Ogawa; H. Itoh; K. Nakao Successful treatment of primary aldosteronism due to computed tomography-negative microadenoma Successful treatment of primary aldosteronism due to computed tomography-negative microadenoma Successful treatment of primary aldosteronism due to computed tomography-negative microadenoma International Journal of Urology, 10, 10, 544-546 International Journal of Urology, 10, 10, 544-546 International Journal of Urology, 10, 10, 544-546 2003/10 Refereed English Disclose to all
T. Kobayashi; E. Nakamura; S. Yamamoto; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; T. Terachi; K. Fujikawa; S. Fukuzawa; H. Takeuchi; O. Ogawa T. Kobayashi; E. Nakamura; S. Yamamoto; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; T. Terachi; K. Fujikawa; S. Fukuzawa; H. Takeuchi; O. Ogawa T. Kobayashi; E. Nakamura; S. Yamamoto; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; T. Terachi; K. Fujikawa; S. Fukuzawa; H. Takeuchi; O. Ogawa Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: A retrospective analysis of 393 patients Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: A retrospective analysis of 393 patients Low incidence of ipsilateral adrenal involvement and recurrences in patients with renal cell carcinoma undergoing radical nephrectomy: A retrospective analysis of 393 patients Urology, 62, 1, 40-45 Urology, 62, 1, 40-45 Urology, 62, 1, 40-45 2003/07 Refereed English Disclose to all
L. Gunaratnam; M. Morley; A. Franovic; N. De Paulsen; K. Mekhail; D.A.E. Parolin; E. Nakamura; I.A.J. Lorimer; S. Lee L. Gunaratnam; M. Morley; A. Franovic; N. De Paulsen; K. Mekhail; D.A.E. Parolin; E. Nakamura; I.A.J. Lorimer; S. Lee L. Gunaratnam; M. Morley; A. Franovic; N. De Paulsen; K. Mekhail; D.A.E. Parolin; E. Nakamura; I.A.J. Lorimer; S. Lee Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL<sup>-/-</sup> Renal Cell Carcinoma Cells Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL<sup>-/-</sup> Renal Cell Carcinoma Cells Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL<sup>-/-</sup> Renal Cell Carcinoma Cells Journal of Biological Chemistry, 278, 45, 44966-44974 Journal of Biological Chemistry, 278, 45, 44966-44974 Journal of Biological Chemistry, 278, 45, 44966-44974 2003 Refereed English Disclose to all
E. Nakamura; Y. Megumi; T. Kobayashi; T. Kamoto; S. Ishitoya; T. Terachi; M. Tachibana; H. Matsushiro; T. Habuchi; Y. Kakehi; O. Ogawa E. Nakamura; Y. Megumi; T. Kobayashi; T. Kamoto; S. Ishitoya; T. Terachi; M. Tachibana; H. Matsushiro; T. Habuchi; Y. Kakehi; O. Ogawa E. Nakamura; Y. Megumi; T. Kobayashi; T. Kamoto; S. Ishitoya; T. Terachi; M. Tachibana; H. Matsushiro; T. Habuchi; Y. Kakehi; O. Ogawa Genetic polymorphisms of the interleukin-4 receptor α gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population Genetic polymorphisms of the interleukin-4 receptor α gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population Genetic polymorphisms of the interleukin-4 receptor α gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population Clinical Cancer Research, 8, 8, 2620-2625 Clinical Cancer Research, 8, 8, 2620-2625 Clinical Cancer Research, 8, 8, 2620-2625 2002/08 Refereed English Disclose to all
T. Kobayashi; S. Yamamoto; E. Nakamura; T. Kamato; Y. Kakehi; O. Ogawa; N. Ito; T. Fukuyama; M. Hishizawa; T. Ichinohe T. Kobayashi; S. Yamamoto; E. Nakamura; T. Kamato; Y. Kakehi; O. Ogawa; N. Ito; T. Fukuyama; M. Hishizawa; T. Ichinohe T. Kobayashi; S. Yamamoto; E. Nakamura; T. Kamato; Y. Kakehi; O. Ogawa; N. Ito; T. Fukuyama; M. Hishizawa; T. Ichinohe Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: A case report Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: A case report Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: A case report Japanese Journal of Clinical Oncology, 32, 1, 33-34 Japanese Journal of Clinical Oncology, 32, 1, 33-34 Japanese Journal of Clinical Oncology, 32, 1, 33-34 2002/01 Refereed English Disclose to all
E. Nakamura; T. Terachi; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; O. Ogawa E. Nakamura; T. Terachi; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; O. Ogawa E. Nakamura; T. Terachi; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; O. Ogawa Retroperitoneoscopic ureterocutaneostomy for obstructive uropathy with advanced bladder cancer: A case report Retroperitoneoscopic ureterocutaneostomy for obstructive uropathy with advanced bladder cancer: A case report Retroperitoneoscopic ureterocutaneostomy for obstructive uropathy with advanced bladder cancer: A case report International Journal of Urology, 9, 1, 60-62 International Journal of Urology, 9, 1, 60-62 International Journal of Urology, 9, 1, 60-62 2002 Refereed English Disclose to all
T. Kobayashi; H. Okuno; H. Nishiyama; E. Nakamura; O. Ogawa; M. Kawahara; A. Shimatsu T. Kobayashi; H. Okuno; H. Nishiyama; E. Nakamura; O. Ogawa; M. Kawahara; A. Shimatsu T. Kobayashi; H. Okuno; H. Nishiyama; E. Nakamura; O. Ogawa; M. Kawahara; A. Shimatsu Adult-onset idiopathic hypogonadotropic hypogonadism presented with erectile and ejaculatory disorder Adult-onset idiopathic hypogonadotropic hypogonadism presented with erectile and ejaculatory disorder Adult-onset idiopathic hypogonadotropic hypogonadism presented with erectile and ejaculatory disorder International Journal of Urology, 9, 10, 604-606 International Journal of Urology, 9, 10, 604-606 International Journal of Urology, 9, 10, 604-606 2002 Refereed English Disclose to all
K. Kondo; J. Klco; E. Nakamura; M. Lechpammer; W.G. Kaelin Jr. K. Kondo; J. Klco; E. Nakamura; M. Lechpammer; W.G. Kaelin Jr. K. Kondo; J. Klco; E. Nakamura; M. Lechpammer; W.G. Kaelin Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein Cancer Cell, 1, 3, 237-246 Cancer Cell, 1, 3, 237-246 Cancer Cell, 1, 3, 237-246 2002 Refereed English Disclose to all
K. Nishizawa; E. Nakamura; G. Kobori; T. Kobayashi; S. Yamamoto; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; O. Ogawa; H. Ueda; T. Yamaoka; N. Kadowaki K. Nishizawa; E. Nakamura; G. Kobori; T. Kobayashi; S. Yamamoto; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; O. Ogawa; H. Ueda; T. Yamaoka; N. Kadowaki K. Nishizawa; E. Nakamura; G. Kobori; T. Kobayashi; S. Yamamoto; T. Kamoto; H. Okuno; A. Terai; Y. Kakehi; O. Ogawa; H. Ueda; T. Yamaoka; N. Kadowaki A case of giant perirenal malignant lymphoma: A case report A case of giant perirenal malignant lymphoma: A case report A case of giant perirenal malignant lymphoma: A case report Acta Urologica Japonica, 48, 3, 175-178 Acta Urologica Japonica, 48, 3, 175-178 Acta Urologica Japonica, 48, 3, 175-178 2002 Refereed English Disclose to all
H. Okuno; E. Nakamura; H. Onishi; Y. Shichiri; Y. Kakehi; O. Ogawa H. Okuno; E. Nakamura; H. Onishi; Y. Shichiri; Y. Kakehi; O. Ogawa Clinical significance of varicocelectomy for male infertility Clinical significance of varicocelectomy for male infertility Japanese Journal of Fertility and Sterility, 45, 4, 333-337 Japanese Journal of Fertility and Sterility, 45, 4, 333-337 , 45, 4, 333-337 2000 Refereed Japanese Disclose to all
H. Okuno; E. Nakamura; Y. Shichiri; Y. Kakehi; T. Terachi; O. Ogawa H. Okuno; E. Nakamura; Y. Shichiri; Y. Kakehi; T. Terachi; O. Ogawa H. Okuno; E. Nakamura; Y. Shichiri; Y. Kakehi; T. Terachi; O. Ogawa Epididymal sperm aspiration for obstructive azoospermia Epididymal sperm aspiration for obstructive azoospermia Epididymal sperm aspiration for obstructive azoospermia Acta Urologica Japonica, 46, 8, 581-586 Acta Urologica Japonica, 46, 8, 581-586 Acta Urologica Japonica, 46, 8, 581-586 2000 Refereed English Disclose to all
K. Tomita; M. Hattori; E. Nakamura; S. Nakanishi; N. Minato; R. Kageyama K. Tomita; M. Hattori; E. Nakamura; S. Nakanishi; N. Minato; R. Kageyama K. Tomita; M. Hattori; E. Nakamura; S. Nakanishi; N. Minato; R. Kageyama The bHLH gene Hes1 is essential for expansion of early T cell precursors The bHLH gene Hes1 is essential for expansion of early T cell precursors The bHLH gene Hes1 is essential for expansion of early T cell precursors Genes and Development, 13, 9, 1203-1210 Genes and Development, 13, 9, 1203-1210 Genes and Development, 13, 9, 1203-1210 1999/05/01 Refereed English Disclose to all
E. Nakamura; M. Sato; H. Yang; F. Miyagawa; M. Harasaki; K. Tomita; S. Matsuoka; A. Noma; K. Iwai; N. Minato E. Nakamura; M. Sato; H. Yang; F. Miyagawa; M. Harasaki; K. Tomita; S. Matsuoka; A. Noma; K. Iwai; N. Minato E. Nakamura; M. Sato; H. Yang; F. Miyagawa; M. Harasaki; K. Tomita; S. Matsuoka; A. Noma; K. Iwai; N. Minato 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer Journal of Biological Chemistry, 274, 5, 3009-3016 Journal of Biological Chemistry, 274, 5, 3009-3016 Journal of Biological Chemistry, 274, 5, 3009-3016 1999/01/29 Refereed English Disclose to all
J. Yamaoka; E. Nakamura; Y. Takeda; S. Imamura; N. Minato J. Yamaoka; E. Nakamura; Y. Takeda; S. Imamura; N. Minato J. Yamaoka; E. Nakamura; Y. Takeda; S. Imamura; N. Minato Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C Infection and Immunity, 66, 10, 5020-5026 Infection and Immunity, 66, 10, 5020-5026 Infection and Immunity, 66, 10, 5020-5026 1998 Refereed English Disclose to all
X.-X. Wu; Y. Mizutani; Y. Kakehi; E. Nakamura; K. Mitsumori; T. Takahashi; T. Terachi; Y. Okada; O. Yoshida X.-X. Wu; Y. Mizutani; Y. Kakehi; E. Nakamura; K. Mitsumori; T. Takahashi; T. Terachi; Y. Okada; O. Yoshida Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-α and/or cimetidine on the expression Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-α and/or cimetidine on the expression Acta Urologica Japonica, 44, 9, 621-626 Acta Urologica Japonica, 44, 9, 621-626 , 44, 9, 621-626 1998 Refereed Japanese Disclose to all
E. Özdemir; Y. Kakehi; E. Nakamura; H. Kinoshita; T. Terachi; Y. Okada; O. Yoshida E. Özdemir; Y. Kakehi; E. Nakamura; H. Kinoshita; T. Terachi; Y. Okada; O. Yoshida E. Özdemir; Y. Kakehi; E. Nakamura; H. Kinoshita; T. Terachi; Y. Okada; O. Yoshida HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma Cancer Research, 57, 4, 742-746 Cancer Research, 57, 4, 742-746 Cancer Research, 57, 4, 742-746 1997 Refereed English Disclose to all
E. Nakamura; H. Kubota; M. Sato; T. Sugie; O. Yoshida; N. Minato E. Nakamura; H. Kubota; M. Sato; T. Sugie; O. Yoshida; N. Minato E. Nakamura; H. Kubota; M. Sato; T. Sugie; O. Yoshida; N. Minato Involvement of NK1<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> αβ T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice Involvement of NK1<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> αβ T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice Involvement of NK1<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> αβ T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice Journal of Immunology, 158, 11, 5338-5348 Journal of Immunology, 158, 11, 5338-5348 Journal of Immunology, 158, 11, 5338-5348 1997 Refereed English Disclose to all
T. Sugie; H. Kubota; M. Sato; E. Nakamura; M. Imamura; N. Minato T. Sugie; H. Kubota; M. Sato; E. Nakamura; M. Imamura; N. Minato T. Sugie; H. Kubota; M. Sato; E. Nakamura; M. Imamura; N. Minato NK 1<sup>+</sup> CD4<sup>-</sup> CD8<sup>-</sup> αß T Cells in the Peritoneal Cavity: Specific T Cell Receptor-Mediated Cytotoxicity and Selective IFN-γ Production Against B Cell Leukemia and Myeloma Cells NK 1<sup>+</sup> CD4<sup>-</sup> CD8<sup>-</sup> αß T Cells in the Peritoneal Cavity: Specific T Cell Receptor-Mediated Cytotoxicity and Selective IFN-γ Production Against B Cell Leukemia and Myeloma Cells NK 1<sup>+</sup> CD4<sup>-</sup> CD8<sup>-</sup> αß T Cells in the Peritoneal Cavity: Specific T Cell Receptor-Mediated Cytotoxicity and Selective IFN-γ Production Against B Cell Leukemia and Myeloma Cells Journal of Immunology, 157, 9, 3925-3935 Journal of Immunology, 157, 9, 3925-3935 Journal of Immunology, 157, 9, 3925-3935 1996 Refereed English Disclose to all
H. Kinoshita; H. Yamada; O. Ogawa; Y. Kakehi; M. Osaka; E. Nakamura; M. Mishina; T. Habuchi; R. Takahashi; T. Sugiyama; O. Yoshida H. Kinoshita; H. Yamada; O. Ogawa; Y. Kakehi; M. Osaka; E. Nakamura; M. Mishina; T. Habuchi; R. Takahashi; T. Sugiyama; O. Yoshida H. Kinoshita; H. Yamada; O. Ogawa; Y. Kakehi; M. Osaka; E. Nakamura; M. Mishina; T. Habuchi; R. Takahashi; T. Sugiyama; O. Yoshida Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma Japanese Journal of Cancer Research, 86, 9, 795-799 Japanese Journal of Cancer Research, 86, 9, 795-799 Japanese Journal of Cancer Research, 86, 9, 795-799 1995 Refereed English Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
梶田洋一郎,布留守敏,長山聡,加藤友久,青山朋樹,西山博之,中村英二郎,賀本敏行,小川修,戸口田淳也 梶田洋一郎,布留守敏,長山聡,加藤友久,青山朋樹,西山博之,中村英二郎,賀本敏行,小川修,戸口田淳也 Sp3は新規肉腫転移関連遺伝子C7059の発現を制御する Sp3は新規肉腫転移関連遺伝子C7059の発現を制御する 第68回日本癌学会総会(2009.10.1.横浜) 第68回日本癌学会総会(2009.10.1.横浜) 2009 Refereed Japanese Disclose to all
Yoichiro Kajita,Moritoshi Furu, Satoshi Nagayama, Hiroytuki Nishiyama, Eijiro Nakamura, Osamu Ogwa, Junya Toguchida Yoichiro Kajita,Moritoshi Furu, Satoshi Nagayama, Hiroytuki Nishiyama, Eijiro Nakamura, Osamu Ogwa, Junya Toguchida Yoichiro Kajita,Moritoshi Furu, Satoshi Nagayama, Hiroytuki Nishiyama, Eijiro Nakamura, Osamu Ogwa, Junya Toguchida Functional analysis of a novel soft tissue sarcoma metastasis-associated molecule in prostate cancer Functional analysis of a novel soft tissue sarcoma metastasis-associated molecule in prostate cancer Functional analysis of a novel soft tissue sarcoma metastasis-associated molecule in prostate cancer 第30 回Congress of Societe Internationale d’Urologie 国際泌尿器科学会 (2009.11.4.Shanghai) 第30 回Congress of Societe Internationale d’Urologie 国際泌尿器科学会 (2009.11.4.Shanghai) 第30 回Congress of Societe Internationale d’Urologie 国際泌尿器科学会 (2009.11.4.Shanghai) 2009 Refereed English Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
挑戦的萌芽研究 Representative Atypical PKC経路を標的とした腎細胞癌に対する新規抗癌活性化合物の同定 2012-2013
挑戦的萌芽研究 Representative ライブラリースクリーニングを用いたCRPCに対する新規創薬標的分子の探索 (平成26年度分) 2014/04/01-2015/03/31
挑戦的萌芽研究 Representative ライブラリースクリーニングを用いたCRPCに対する新規創薬標的分子の探索 (平成27年度分) 2015/04/01-2016/03/31
挑戦的萌芽研究 Representative AR-V7陽性新規前立腺癌細胞株を用いたCRPCに対する創薬標的探索 (平成28年度分) 2016/04/01-2017/03/31
難治性疾患等政策研究事業(難治性疾患政策研究事業) Assignment (平成28年度分) 2016/04/01-2017/03/31
挑戦的萌芽研究 Representative AR-V7陽性新規前立腺癌細胞株を用いたCRPCに対する創薬標的探索 (平成29年度分) 2017/04/01-2018/03/31
基盤研究(B) Representative 患者由来iPS細胞を用いたVHL病新規病態モデルの構築 (平成29年度分) 2017/04/01-2018/03/31
障害者政策総合研究事業(精神障害分野) Assignment (平成29年度分) 2017/04/01-2018/03/31
基盤研究(B) Representative 患者由来iPS細胞を用いたVHL病新規病態モデルの構築 (平成30年度分) 2018/04/01-2019/03/31
External funds: other than those above
System Main person Title(Japanese) Title(English) Period
京都発革新的医療技術研究開発助成事業 中村 英二郎 家族性腫瘍患者 iPS細胞を用いた新規抗癌剤の開発 (平成27年度分) 2015/04/01-2016/03/31